FDA recall D-0382-2019

Cipla Limited · Class II · drug

Product

Nevirapine Extended Release Tablets, 400 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd. Verna Goa, India, Manufactured for: Cipla USA Inc. 9100 S Dadeland Blvd., Suite 1500 Miami, FL 33156, NDC 69097-403-02

Reason for recall

Failed Dissolution Specifications.

Distribution

Nationwide within the United States

Key facts

Status
Terminated
Initiation date
2018-12-14
Report date
2018-12-26
Termination date
2020-07-08
Voluntary/Mandated
Voluntary: Firm initiated
Location
Vasco Da Gama, India

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0382-2019